Research Study of an investigational drug to help treat generalized anxiety disorder when current treatment is inadequate.
See If You Are Eligible
-Requirements:
-Age: 18 years of age or older
-Condition: Diagnosis of Generalized Anxiety Disorder (GAD)
-Treatment: Currently having an inadequate response to one of the following GAD-approved treatments:
*Paroxetine (Aropax®, Paxil®, Pexeva®, Seroxat®, Sereupin®, Brisdelle®)
*Venlafaxine XR (Effexor XR®)
*Duloxetine (Cymbalta®, Yentreve®)
*Escitalopram (Lexapro®, Cipralex®)
*Buspirone (BuSpar®)